免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

內骨骼至間體融合設備(IBD)

K 號:K170399 · 2017-07-06

決定日期2017-07-06
產品代碼MAX
諮詢委員會或
決定相當於

器材摘要

Endoskeleton TO Interbody Fusion Device (IBD) is the device name listed in this FDA 510(k) record. The listed applicant is Titan Spine, LLC. It received FDA 510(k) clearance on 2017-07-06 under 510(k) number K170399. The device is classified under product code MAX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Endoskeleton TO Interbody Fusion Device (IBD)?

Endoskeleton TO Interbody Fusion Device (IBD) is a medical device that received FDA 510(k) clearance on 2017-07-06. The listed applicant is Titan Spine, LLC. The 510(k) number is K170399.

When did Endoskeleton TO Interbody Fusion Device (IBD) receive FDA 510(k) clearance?

Endoskeleton TO Interbody Fusion Device (IBD) received FDA 510(k) clearance on 2017-07-06, under 510(k) number K170399.

Who is the listed applicant for Endoskeleton TO Interbody Fusion Device (IBD)?

The FDA 510(k) record lists Titan Spine, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Endoskeleton TO Interbody Fusion Device (IBD)?

The FDA product code for Endoskeleton TO Interbody Fusion Device (IBD) is MAX.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Titan Spine, LLC 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:MAX)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑